Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)
Clinical trial NCT03614663 · COMPLETED
Trial details
- NCT number
- NCT03614663
- Sponsor
- Zynerba Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-12
- Primary completion
- 2020-06-14
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.